401
Views
1
CrossRef citations to date
0
Altmetric
The NISS Special Series: The NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

Rejoinder: Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 119-124 | Received 15 Dec 2022, Accepted 22 Dec 2022, Published online: 07 Feb 2023
 

We would like to thank the discussants Mouna Akacha, Tianmeng Lyu, and Stijn Vansteelandt for their interesting and thoughtful comments on our paper “Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions.” (Van Lancker et al., Citation2022). We also would like to extend our gratitude to Toshimitsu Hamasaki for making this a discussion article.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.